ArticleCanadian family physician Medecin de famille canadien2006
Natural history of elevated creatinine levels.
Article in Canadian family physician Medecin de famille canadien, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 4 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate what happens to the serum creatinine (SC) levels of people with initial mild elevations in SC; whether a stable, non-progressive elevation in SC level is the most common scenario; how common a progressive increase in SC is among primary care patients; and how often primary care patients with substantial elevations in SC (>300 micromol/L) progress to end-stage renal disease.
designRetrospective analysis of laboratory data and chart review.
settingQueen's University Family Medicine Centre in Kingston, Ont.
participantsAll patients who had SC levels measured at a nearby hospital laboratory between January 1994 and December 1998.
main outcome measuresRecently recorded height and weight measurements, latest SC measurements (if available), whether patients had been referred to nephrologists, comorbidity, medications being taken, whether patients were currently undergoing dialysis or had received a renal transplant, and whether patients had died.
resultsIn the 1434 charts of eligible patients, 64 (4.5%) had elevated initial SC levels (>130 micromol/L) recorded, and 57 of these contained follow-up SC levels also. Among these 57 patients, 32 (56%) saw their SC levels return to normal, including 50% of those whose initial levels had been >300 micromol/L. Only 7 patients (12%) with elevated SC levels progressed to higher levels during the follow-up period. Average age in the study group was 63 years; those with initial elevated SC levels were older than the average (70 years).
conclusionMore than half of those with initially elevated SC levels (>130 micromol/L) saw their levels return to normal, including patients whose initial levels had been >300 micromol/L. It seems that a single elevated SC measurement does not predict ongoing decline in renal function.
Indexed as
Identifiers
17279186PMC1783607W2186879703What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.